Analytical Data
-
Gene name
CREG1
- Application
-
Alternative Names
CREG1；CREG;Protein CREG1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O75629
-
Expression Region
32-220aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSMRGGRDH GDWDEASRLP PLPPREDAAR VARFVTHVSD WGALATISTL EAVRGRPFAD VLSLSDGPPG AGSGVPYFYL SPLQLSVSNL QENPYATLTM TLAQTNFCKK HGFDPQSPLC VHIMLSGTVT KVNETEMDIA KHSLFIRHPE MKTWPSSHNW FFAKLNITNI WVLDYFGGPK IVTPEEYYNV TVQ
-
Molecular Weight
24 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CREG1 (Cellular Repressor of E1A Stimulated Genes 1) is a protein that has garnered significant interest in biomedical research due to its role in various cellular processes, including cell proliferation, differentiation, and response to stress. Initially identified as a regulator of cellular growth influenced by the E1A protein, CREG1 has been implicated in numerous pathological conditions, including cancer and cardiovascular diseases. Its expression is often dysregulated in tumor tissues, suggesting a potential role in tumorigenesis and metastasis. Furthermore, recent studies have highlighted CREG1's involvement in modulating inflammation and tissue repair, positioning it as a critical factor in regenerative medicine. The exploration of CREG1 as a recombinant protein holds promise for elucidating its functional mechanisms and therapeutic potential. Researchers are investigating its structure-function relationships, signaling pathways, and interactions with other proteins, aiming to harness its properties for novel clinical applications. Advances in recombinant protein technology have enabled the production of CREG1 in heterologous systems, facilitating detailed functional assays and drug development. Understanding the biological implications of CREG1 through recombinant protein studies could pave the way for innovative strategies in cancer therapy, regenerative medicine, and inflammatory diseases, maximizing its translational potential in clinical settings.
